Campbell & CO Investment Adviser LLC Makes New Investment in Encompass Health Corporation $EHC

Key Points

• Campbell & CO Investment Adviser LLC acquired 20,191 shares of Encompass Health Corporation, valued at approximately $2,045,000, indicating strong interest from institutional investors.
• Encompass Health reported $1.40 earnings per share for the last quarter, exceeding estimates and showing 12.0% revenue growth year-over-year.
• The company's recent dividend increase to $0.19 per share reflects a 0.6% yield, demonstrating financial stability and commitment to returning value to shareholders.

Campbell & CO Investment Adviser LLC purchased a new stake in shares of Encompass Health Corporation (NYSE:EHC - Free Report) during the 1st quarter, according to its most recent disclosure with the SEC. The fund purchased 20,191 shares of the company's stock, valued at approximately $2,045,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Invesco Ltd. grew its holdings in Encompass Health by 5.1% during the 1st quarter. Invesco Ltd. now owns 5,818,783 shares of the company's stock worth $589,326,000 after acquiring an additional 282,532 shares during the last quarter. T. Rowe Price Investment Management Inc. grew its holdings in Encompass Health by 25.6% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 2,080,918 shares of the company's stock worth $210,756,000 after acquiring an additional 424,691 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in Encompass Health by 5.3% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,871,581 shares of the company's stock worth $189,549,000 after acquiring an additional 93,992 shares during the last quarter. Price T Rowe Associates Inc. MD grew its holdings in Encompass Health by 13.1% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 1,822,376 shares of the company's stock worth $184,571,000 after acquiring an additional 211,707 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. grew its holdings in Encompass Health by 11.9% during the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 1,541,477 shares of the company's stock worth $156,121,000 after acquiring an additional 163,400 shares during the last quarter. 97.25% of the stock is owned by institutional investors.

Encompass Health Stock Down 1.4%

Shares of Encompass Health stock traded down $1.74 during trading on Friday, reaching $121.71. 839,898 shares of the company traded hands, compared to its average volume of 862,588. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06. Encompass Health Corporation has a 1-year low of $87.85 and a 1-year high of $124.67. The company has a 50 day moving average price of $116.66 and a 200-day moving average price of $111.15. The firm has a market capitalization of $12.26 billion, a PE ratio of 23.82, a P/E/G ratio of 2.13 and a beta of 0.86.

Encompass Health (NYSE:EHC - Get Free Report) last released its earnings results on Monday, August 4th. The company reported $1.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.20 by $0.20. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The company had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. During the same quarter in the previous year, the company earned $1.11 EPS. Encompass Health's quarterly revenue was up 12.0% compared to the same quarter last year. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. As a group, equities research analysts expect that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be given a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Wednesday, October 1st. This is a boost from Encompass Health's previous quarterly dividend of $0.17. Encompass Health's dividend payout ratio is presently 13.31%.

Insider Activity

In related news, EVP Patrick William Tuer sold 1,020 shares of the business's stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the transaction, the executive vice president owned 18,846 shares in the company, valued at $2,329,177.14. The trade was a 5.13% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.00% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on EHC shares. KeyCorp boosted their target price on shares of Encompass Health from $122.00 to $135.00 and gave the stock an "overweight" rating in a report on Tuesday, May 27th. Wall Street Zen lowered shares of Encompass Health from a "strong-buy" rating to a "buy" rating in a report on Friday, June 6th. Truist Financial boosted their target price on shares of Encompass Health from $135.00 to $140.00 and gave the stock a "buy" rating in a report on Thursday, August 14th. UBS Group boosted their price target on shares of Encompass Health from $130.00 to $140.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. Finally, Stephens upgraded shares of Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target on the stock in a research report on Thursday, June 5th. One research analyst has rated the stock with a Strong Buy rating and six have assigned a Buy rating to the company. According to data from MarketBeat, Encompass Health currently has a consensus rating of "Buy" and a consensus target price of $134.00.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.